FDA Inspection
Hybrid Pharma LLCHybrid Pharma LLC – FDA Inspection, Jun 20, 2019
Record Details
This FDA Inspection record concerns Hybrid Pharma LLC, with an inspection on June 20, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 978cb167-fa24-4d74-94ff-b0396e011b27
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1093987
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
11- 21 CFR 211.42(c)(10)(i)Floors, walls, ceiling surfaces
- 21 CFR 211.42(c)(10)(iii)Air Supply
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.194(a)Complete test data included in records
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- FDCA 503B(a)(10)Drug product label, outsourcer facility
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Showing 10 of 11 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hybrid Pharma LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 9, 2023 | OAI | Drug Quality Assurance | |
| September 3, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 28, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hybrid Pharma LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.